- Home
- BBGI vs RLMD Comparison
BBGI vs RLMD Comparison
Compare BBGI & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- RLMD
- Stock Information
- Founded
- BBGI 1961
- RLMD 2004
- Country
- BBGI United States
- RLMD United States
- Employees
- BBGI N/A
- RLMD N/A
- Industry
- BBGI Broadcasting
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- BBGI Consumer Discretionary
- RLMD Health Care
- Exchange
- BBGI Nasdaq
- RLMD Nasdaq
- Market Cap
- BBGI 13.2M
- RLMD 11.5M
- IPO Year
- BBGI 2000
- RLMD N/A
- Fundamental
- Price
- BBGI $5.25
- RLMD $0.27
- Analyst Decision
- BBGI
- RLMD Hold
- Analyst Count
- BBGI 0
- RLMD 4
- Target Price
- BBGI N/A
- RLMD $4.25
- AVG Volume (30 Days)
- BBGI 5.0K
- RLMD 390.2K
- Earning Date
- BBGI 05-07-2025
- RLMD 05-07-2025
- Dividend Yield
- BBGI N/A
- RLMD N/A
- EPS Growth
- BBGI N/A
- RLMD N/A
- EPS
- BBGI N/A
- RLMD N/A
- Revenue
- BBGI $240,291,611.00
- RLMD N/A
- Revenue This Year
- BBGI $5.02
- RLMD N/A
- Revenue Next Year
- BBGI N/A
- RLMD N/A
- P/E Ratio
- BBGI N/A
- RLMD N/A
- Revenue Growth
- BBGI N/A
- RLMD N/A
- 52 Week Low
- BBGI $5.09
- RLMD $0.24
- 52 Week High
- BBGI $16.00
- RLMD $5.09
- Technical
- Relative Strength Index (RSI)
- BBGI 28.48
- RLMD 41.64
- Support Level
- BBGI $5.78
- RLMD $0.26
- Resistance Level
- BBGI $5.96
- RLMD $0.33
- Average True Range (ATR)
- BBGI 0.21
- RLMD 0.03
- MACD
- BBGI 0.02
- RLMD 0.00
- Stochastic Oscillator
- BBGI 15.81
- RLMD 33.75
Stock Price Comparison Chart: BBGI vs RLMD
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The Company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. The Company owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The Company currently operates three operating segments Audio, Digital and esports.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.